Publications by authors named "Jan Hartstra"

Claim this Profile
R
Rethinking, reducing, and refining the classical oral tyramine challenge test of monoamine oxidase (MAO) inhibitors.
Ewoud-Jan van Hoogdalem, Karen L Smith, Jan Hartstra, John Constant

Clin Transl Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics and - Preliminary Dynamics of Neuroprotectant 2-Iminobiotin in Healthy Subjects.
Ewoud-Jan van Hoogdalem, Cacha M P C D Peeters-Scholte, Paul W T J Leufkens, Jan Hartstra, Jan J van Lier

Curr Clin Pharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.
Gabriel M Fox, Ad F Roffel, Jan Hartstra, Linda A Bussian, Sjoerd P van Marle

Clin Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus.
Armel Stockis, Jan Hartstra, Muriel Mollet, Salah Hadi

Epilepsia· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
Marc Bifano, Carey Hwang, Berend Oosterhuis, Jan Hartstra, Dennis Grasela

Antivir Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis